Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Calandra

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Molecular Psychiatry|February 24, 2010
Macrophage migration inhibitory factor is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression, and memory-related behaviorsL Conboy, E Varea, J E Castro, et al.
Biochemistry|January 10, 1998
Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factorK Bendrat, Y Al-Abed, D J Callaway, et al.
Antimicrobial Agents and Chemotherapy|July 14, 2010
High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal functionF Lamoth, T Buclin, A Pascual, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 3, 2006
Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patientsC Viscoli, A Cometta, W V Kern, et al.
Molecular Endocrinology (Baltimore, Md.)|May 30, 1998
Transcriptional activation of the macrophage migration-inhibitory factor gene by the corticotropin-releasing factor is mediated by the cyclic adenosine 3',5'- monophosphate responsive element-binding protein CREB in pituitary cellsG Waeber, N Thompson, T Chautard, et al.
Nature|September 7, 1995
MIF as a glucocorticoid-induced modulator of cytokine productionT Calandra, J Bernhagen, C N Metz, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 1996
An essential regulatory role for macrophage migration inhibitory factor in T-cell activationM Bacher, C N Metz, T Calandra, et al.
Critical Care Medicine|May 25, 2001
New strategies for clinical trials in patients with sepsis and septic shockJ Cohen, G Guyatt, G R Bernard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14D Le Roy, F Di Padova, R Tees, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC)C Viscoli, P Bruzzi, E Castagnola, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Molecular Psychiatry|February 24, 2010
Macrophage migration inhibitory factor is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression, and memory-related behaviorsL Conboy, E Varea, J E Castro, et al.
Biochemistry|January 10, 1998
Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factorK Bendrat, Y Al-Abed, D J Callaway, et al.
Antimicrobial Agents and Chemotherapy|July 14, 2010
High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal functionF Lamoth, T Buclin, A Pascual, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 3, 2006
Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patientsC Viscoli, A Cometta, W V Kern, et al.
Molecular Endocrinology (Baltimore, Md.)|May 30, 1998
Transcriptional activation of the macrophage migration-inhibitory factor gene by the corticotropin-releasing factor is mediated by the cyclic adenosine 3',5'- monophosphate responsive element-binding protein CREB in pituitary cellsG Waeber, N Thompson, T Chautard, et al.
Nature|September 7, 1995
MIF as a glucocorticoid-induced modulator of cytokine productionT Calandra, J Bernhagen, C N Metz, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 1996
An essential regulatory role for macrophage migration inhibitory factor in T-cell activationM Bacher, C N Metz, T Calandra, et al.
Critical Care Medicine|May 25, 2001
New strategies for clinical trials in patients with sepsis and septic shockJ Cohen, G Guyatt, G R Bernard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14D Le Roy, F Di Padova, R Tees, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC)C Viscoli, P Bruzzi, E Castagnola, et al.
Pageof 10